Director at Encompass Health (NYSE: EHC) gains stock via RSUs and deferrals
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Encompass Health Corp director Edward M. Christie III reported acquiring additional common stock through compensation-related programs. On April 16, he received 261 shares at a weighted average price of $106.17 per share, tied to restricted stock units that accrue additional units when common stock dividends are paid.
The RSU credit was based on a $0.19 per share dividend paid on April 15 and a closing price of $105.24 on that date. He also acquired 9 shares on April 15 through the Directors Deferred Stock Investment Plan, where deferred director fees and associated dividends are used to purchase Encompass Health common stock in the market. Following these awards, he directly holds 7,452 shares of Encompass Health common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Christie Edward M III
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Encompass Health Common Stock | 261 | $106.17 | $28K |
| Grant/Award | Encompass Health Common Stock | 9 | $0.00 | -- |
Holdings After Transaction:
Encompass Health Common Stock — 7,452 shares (Direct)
Footnotes (1)
- Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2025 to defer fixed percentages of their director fees for 2026. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the director's fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly fee deferral and the dividend of $0.19 per share paid on April 15, 2026. This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $106.11 to $106.17, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Key Figures
RSU-related shares acquired: 261 shares
Weighted average price: $106.17 per share
Shares from deferred fees and dividends: 9 shares
+3 more
6 metrics
RSU-related shares acquired
261 shares
Common stock credited on April 16, 2026
Weighted average price
$106.17 per share
Price range $106.11–$106.17 for RSU-related purchase
Shares from deferred fees and dividends
9 shares
Purchased under Directors Deferred Stock Investment Plan on April 15, 2026
Dividend per share
$0.19 per share
Common stock dividend paid April 15, 2026
Closing price on dividend date
$105.24 per share
Used to calculate RSUs credited on April 15, 2026
Total shares after transactions
7,452 shares
Director’s direct Encompass Health common stock holdings
Key Terms
restricted stock units, non-qualified deferral plan, weighted average price, dividend reinvestment
4 terms
restricted stock units financial
"additional restricted stock units ("RSUs") are credited to each non-employee director's account"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
non-qualified deferral plan financial
"The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan"
weighted average price financial
"This per share price is a weighted average price. These shares were purchased in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
dividend reinvestment financial
"such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
FAQ
What insider transactions did Encompass Health (EHC) director Edward M. Christie III report?
He reported acquiring Encompass Health common stock in two compensation-related transactions, not open-market discretionary purchases. One reflected restricted stock units credited from a dividend, and the other came from director fee deferrals and dividend reinvestment into company shares.
What is the role of restricted stock units in this Encompass Health (EHC) Form 4?
Restricted stock units for non-employee directors are credited with additional units when dividends are paid on Encompass Health common stock. The 261-share award reflects RSUs associated with a $0.19 per share dividend and a $105.24 closing price used in calculating the credited units.
How does the Directors Deferred Stock Investment Plan work at Encompass Health (EHC)?
The Directors Deferred Stock Investment Plan lets non-employee directors defer portions of their fees. Deferred amounts are used quarterly to buy Encompass Health common stock in the market, and dividends on that stock are reinvested, increasing each participating director’s share holdings over time.